Phase II study of pomegranate juice for men with rising PSA following surgery or radiation for prostate cancer

被引:5
|
作者
Pantuck, AJ
Leppert, JT
Zomorodian, N
Seeram, N
Seiler, D
Liker, H
Wang, HJ
Elashoff, R
Heber, D
Belldegrun, AS
机构
来源
JOURNAL OF UROLOGY | 2005年 / 173卷 / 04期
关键词
D O I
10.1016/S0022-5347(18)35000-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
831
引用
收藏
页码:225 / 226
页数:2
相关论文
共 50 条
  • [21] Prognostic Significance of Rising Prostate-Specific Antigen (PSA) Levels Following Radiation Therapy for Localized Prostate Cancer-Comparison Between PSA Bounce Versus PSA Recurrence
    Freiberger, C.
    Schmitt, V.
    Eble, M. J.
    Pinkawa, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E285 - E286
  • [22] Natural history of rising serum PSA in men with castrate nonmetastatic prostate cancer.
    Smith, MR
    Kabbinavar, F
    Saad, F
    Hussain, A
    Hei, YJ
    Small, E
    Cook, R
    Higano, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 381S - 381S
  • [23] Phase II study of sunitinib in men with advanced prostate cancer
    Michaelson, M. Dror
    Regan, M. M.
    Oh, W. K.
    Kaufman, D. S.
    Olivier, K.
    Michaelson, S. Z.
    Spicer, B.
    Gurski, C.
    Kantoff, P. W.
    Smith, M. R.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 913 - 920
  • [24] A phase II trial of lapatinib (GW572016) in patients with recurrent prostate cancer as evident by a rising PSA
    Chen, Y.
    Wilding, G.
    Gee, J.
    DiPaola, R. P.
    Pins, M.
    Carducci, M. A.
    Stein, M. N.
    Bubley, G.
    Liu, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] A phase II study of nilutamide in men with prostate cancer following failure of flutamide or bicalutamide therapy.
    Davis, NB
    Ryan, CW
    Stadler, WM
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 423S - 423S
  • [27] A phase II trial of an adenovirus/PSA vaccine for prostate cancer
    Lubaroff, D. M.
    Vaena, D. A.
    Williams, R. D.
    Joudi, F. N.
    Smith, M. C.
    Zehr, P. S.
    Eastman, J.
    Griffith, K.
    Madsen, T. M.
    Johnson, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Evaluating non -hormonal therapy in a phase II trial of SM-88 for rising PSA prostate cancer.
    Gartrell, Benjamin Adam
    Del Priore, Giuseppe
    Retter, Avi S.
    Chen, Wen-Tien
    Sokol, Gerald H.
    Vandell, Alexander G.
    Roach, Mack
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [29] The PSA response following radical radiation therapy for localized prostate cancer
    Zietman, AL
    Smith, CT
    Shipley, WU
    RECENT ADVANCES IN PROSTATE CANCER AND BPH, 1997, : 241 - 252
  • [30] A phase II trial of gefitinib in patients with rising PSA following radical prostatectomy or radiotherapy
    Joensuu, Greetta
    Joensuu, Timo
    Nupponen, Nina
    Ruutu, Mirja
    Collan, Juhani
    Pesonen, Sari
    Hemminki, Akseli
    ACTA ONCOLOGICA, 2012, 51 (01) : 130 - U170